Novaquest Capital Management
Venture capital · Raleigh, North Carolina, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio3 active
1Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Gossamer Bio
11Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Cardurion Pharmaceuticals | Biotech | Active | Jul 24, 2024 | $349.7M |
| FibroGen | Biotech | Active | Dec 10, 2014 | $20.0M |
| Angitia Biopharmaceuticals | Biotech | Active | — | — |
| Gossamer Bio | Biotech | Public | Sep 4, 2026 | $728.1M |
Peer ranks
Portfolio size#108
Portfolio exits#160
Raises, 12 months#22
Co-investors#158
Co-investors
- Atlas VentureVenture capital1 shared
- Bain Capital Life SciencesVenture capital1 shared
- Charter Life SciencesVenture capital1 shared
- Lightstone VenturesVenture capital1 shared
- Longitude CapitalVenture capital1 shared
- New Enterprise AssociatesVenture capital1 shared
- PJCVenture capital1 shared
- RA CapitalVenture capital1 shared
- Telegraph Hill PartnersVenture capital1 shared
- Thomas, McNerney & PartnersVenture capital1 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.